苏州驾玉生物医药有限公司，于2017年5月成立于苏州工业园区内，由“中组部特聘专家“林巧博士领衔创立。公司在2019年6月被评为“姑苏领军企业”，2019年9月在上海张江开始GMP检测业务，2021年中将完成苏州生物检测中心的建设。公司作为全球首家质量管理外包服务机构(Bio-CQO^®)和第三方GMP 安全性和产品质量检测机构，已服务了国内外20多家生物制药企业，包括中国及欧美在抗体、抗体偶联药物，CAR-T及其它细胞基因疗法领域的领军企业。服务内容概括产品全生命周期的药学和质量研究及体系建设与管理，细胞库及药物产品安全性和放行检测，全球IND到BLA的注册申报支持等。驾玉服务的标准根据客户需求，可以达到符合国际人用药品注册技术协调会（ICH）、美国药监局（FDA）、欧盟药品管理局（EMA）中国等全球 GMP 要求。

JADE Biomedical. was founded in Suzhou Industrial Park May 2017 by Dr Claudia Qiao Lin, a "China National Expert” awardee by the Central Organization Department. June 2019, JADE was named "Suzhou Leading Enterprise" for its innovative business model and service scope which is to provide End-to-End Quality Services to the rapidly growing global Biopharmaceutical industry. September 2019, JADE started GMP Testing in Shanghai at Zhangjiang High-tech Park and will complete construction of their new lab facility in Suzhou Biological Testing Center early 2021.

 As the world's first Contract Quality Organization (Bio-CQO^®), Third-party Cell Bank and Product Safety and Release QC Testing Organization, JADE has served over 20 Biopharmaceutical companies globally, including many leading Biopharmas in China and around the world. JADE has also serviced MAHs with products including antibodies, antibody-drug conjugates, and CAR-T cell therapy. JADE Services also include pharmaceutical and quality management of whole product life cycle, product safety, and regulatory filing. According to specific needs of each customer, operational standards of JADE can meet global GMP requirements of the ICH, United States Food & Drug Administration (FDA), European Union Drug Administration (EMA), and China’s NMPA.